HEADER TRANSPORT PROTEIN 18-APR-08 3CVL TITLE STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TITLE 2 TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO T. BRUCEI TITLE 3 PHOSPHOFRUCTOKINASE (PFK) PTS1 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME TARGETING SIGNAL 1 RECEPTOR PEX5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BINDING DOMAIN,UNP RESIDUES 332-655; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: T. BRUCEI PFK PTS1 PEPTIDE AC-HEELAKL; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI; SOURCE 3 ORGANISM_TAXID: 5691; SOURCE 4 GENE: PEX5; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSKB3; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS TPR MOTIFS, TPR PROTEIN, PEROXIN 5, PEX5, PTS1 BINDING DOMAIN, KEYWDS 2 PROTEIN-PEPTIDE COMPLEX, RECEPTOR, TPR REPEAT, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.SAMPATHKUMAR,C.ROACH,P.A.M.MICHELS,W.G.J.HOL REVDAT 6 30-AUG-23 3CVL 1 REMARK REVDAT 5 20-OCT-21 3CVL 1 SEQADV REVDAT 4 24-JAN-18 3CVL 1 AUTHOR REVDAT 3 24-FEB-09 3CVL 1 VERSN REVDAT 2 09-SEP-08 3CVL 1 JRNL REVDAT 1 24-JUN-08 3CVL 0 JRNL AUTH P.SAMPATHKUMAR,C.ROACH,P.A.MICHELS,W.G.HOL JRNL TITL STRUCTURAL INSIGHTS INTO THE RECOGNITION OF PEROXISOMAL JRNL TITL 2 TARGETING SIGNAL 1 BY TRYPANOSOMA BRUCEI PEROXIN 5. JRNL REF J.MOL.BIOL. V. 381 867 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18598704 JRNL DOI 10.1016/J.JMB.2008.05.089 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 14844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 753 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1024 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2298 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 67 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.341 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.253 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.206 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.911 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2385 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1516 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3261 ; 1.368 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3703 ; 1.008 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 307 ; 6.712 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 124 ;38.186 ;25.081 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 360 ;15.802 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;14.135 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2753 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 473 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 625 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1597 ; 0.195 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1168 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1216 ; 0.110 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 83 ; 0.168 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.147 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 64 ; 0.238 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.155 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1926 ; 0.904 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 598 ; 0.151 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2396 ; 1.078 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1009 ; 1.725 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 859 ; 2.502 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CVL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047264. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC VARIMAX OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16165 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080 REMARK 200 RESOLUTION RANGE LOW (A) : 26.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.270 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09600 REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.73 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31700 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB CODE 1FCH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.3M POTASSIUM ACETATE, 0.1M SODIUM REMARK 280 CITRATE MONOHYDRATE, PH 4.8, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.18000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT OF PROTEIN PEX5 IS MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 329 REMARK 465 HIS A 330 REMARK 465 MET A 331 REMARK 465 LEU A 332 REMARK 465 GLN A 333 REMARK 465 ASN A 334 REMARK 465 ASN A 335 REMARK 465 GLY A 454 REMARK 465 SER A 455 REMARK 465 VAL A 456 REMARK 465 ASN A 457 REMARK 465 LEU A 458 REMARK 465 GLN A 459 REMARK 465 ALA A 460 REMARK 465 ASP A 461 REMARK 465 VAL A 462 REMARK 465 ASP A 463 REMARK 465 ILE A 464 REMARK 465 ASP A 465 REMARK 465 ASP A 466 REMARK 465 LEU A 467 REMARK 465 ASN A 468 REMARK 465 VAL A 469 REMARK 465 GLN A 470 REMARK 465 SER A 471 REMARK 465 GLU A 472 REMARK 465 ASP A 473 REMARK 465 THR A 605 REMARK 465 GLY A 606 REMARK 465 GLU A 607 REMARK 465 MET A 653 REMARK 465 LEU A 654 REMARK 465 LEU A 655 REMARK 465 HIS B 1 REMARK 465 GLU B 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 361 CG CD CE NZ REMARK 470 LEU A 362 CG CD1 CD2 REMARK 470 LYS A 415 CG CD CE NZ REMARK 470 PHE A 474 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 483 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 525 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 549 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 589 CG CD CE NZ REMARK 470 SER A 609 OG REMARK 470 ARG A 610 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 634 CG CD OE1 OE2 REMARK 470 LYS A 646 CG CD CE NZ REMARK 470 GLN A 651 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 345 C TYR A 346 N -0.217 REMARK 500 TYR A 346 C MET A 347 N -0.212 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 337 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 TYR A 346 O - C - N ANGL. DEV. = -10.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 351 59.32 -143.01 REMARK 500 ALA A 363 -77.53 -131.31 REMARK 500 ASN A 364 -149.21 146.21 REMARK 500 ALA A 478 71.33 -161.49 REMARK 500 GLN A 583 76.48 -107.69 REMARK 500 ASN A 628 37.81 75.00 REMARK 500 ARG A 629 70.78 -117.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 363 ASN A 364 141.09 REMARK 500 ASN A 364 LEU A 365 -145.44 REMARK 500 THR A 602 THR A 603 -143.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CV0 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH T. BRUCEI PHOSPHOGLUCOISOMERASE (PGI) REMARK 900 PTS1 PEPTIDE REMARK 900 RELATED ID: 3CVN RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED TO T. BRUCEI GLYCERALDEHYDE-3-PHOSPHATE REMARK 900 DEHYDROGENASE (TBGAPDH) PTS1 PEPTIDE REMARK 900 RELATED ID: 3CVP RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEX WITH PTS1 PEPTIDE (10-SKL WITH THE SEQUENCE REMARK 900 ACGTLSNRASKL) REMARK 900 RELATED ID: 3CVQ RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEX WITH PTS1 PEPTIDE (7-SKL WITH THE SEQUENCE REMARK 900 SNRWSKL) DBREF 3CVL A 332 655 UNP Q9U7C3 Q9U7C3_9TRYP 332 655 DBREF 3CVL B 1 7 UNP O15648 O15648_9TRYP 481 487 SEQADV 3CVL GLY A 329 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CVL HIS A 330 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CVL MET A 331 UNP Q9U7C3 EXPRESSION TAG SEQADV 3CVL ALA A 378 UNP Q9U7C3 LYS 378 ENGINEERED MUTATION SEQADV 3CVL ALA A 379 UNP Q9U7C3 GLU 379 ENGINEERED MUTATION SEQRES 1 A 327 GLY HIS MET LEU GLN ASN ASN THR ASP TYR PRO PHE GLU SEQRES 2 A 327 ALA ASN ASN PRO TYR MET TYR HIS GLU ASN PRO MET GLU SEQRES 3 A 327 GLU GLY LEU SER MET LEU LYS LEU ALA ASN LEU ALA GLU SEQRES 4 A 327 ALA ALA LEU ALA PHE GLU ALA VAL CYS GLN ALA ALA PRO SEQRES 5 A 327 GLU ARG GLU GLU ALA TRP ARG SER LEU GLY LEU THR GLN SEQRES 6 A 327 ALA GLU ASN GLU LYS ASP GLY LEU ALA ILE ILE ALA LEU SEQRES 7 A 327 ASN HIS ALA ARG MET LEU ASP PRO LYS ASP ILE ALA VAL SEQRES 8 A 327 HIS ALA ALA LEU ALA VAL SER HIS THR ASN GLU HIS ASN SEQRES 9 A 327 ALA ASN ALA ALA LEU ALA SER LEU ARG ALA TRP LEU LEU SEQRES 10 A 327 SER GLN PRO GLN TYR GLU GLN LEU GLY SER VAL ASN LEU SEQRES 11 A 327 GLN ALA ASP VAL ASP ILE ASP ASP LEU ASN VAL GLN SER SEQRES 12 A 327 GLU ASP PHE PHE PHE ALA ALA PRO ASN GLU TYR ARG GLU SEQRES 13 A 327 CYS ARG THR LEU LEU HIS ALA ALA LEU GLU MET ASN PRO SEQRES 14 A 327 ASN ASP ALA GLN LEU HIS ALA SER LEU GLY VAL LEU TYR SEQRES 15 A 327 ASN LEU SER ASN ASN TYR ASP SER ALA ALA ALA ASN LEU SEQRES 16 A 327 ARG ARG ALA VAL GLU LEU ARG PRO ASP ASP ALA GLN LEU SEQRES 17 A 327 TRP ASN LYS LEU GLY ALA THR LEU ALA ASN GLY ASN ARG SEQRES 18 A 327 PRO GLN GLU ALA LEU ASP ALA TYR ASN ARG ALA LEU ASP SEQRES 19 A 327 ILE ASN PRO GLY TYR VAL ARG VAL MET TYR ASN MET ALA SEQRES 20 A 327 VAL SER TYR SER ASN MET SER GLN TYR ASP LEU ALA ALA SEQRES 21 A 327 LYS GLN LEU VAL ARG ALA ILE TYR MET GLN VAL GLY GLY SEQRES 22 A 327 THR THR PRO THR GLY GLU ALA SER ARG GLU ALA THR ARG SEQRES 23 A 327 SER MET TRP ASP PHE PHE ARG MET LEU LEU ASN VAL MET SEQRES 24 A 327 ASN ARG PRO ASP LEU VAL GLU LEU THR TYR ALA GLN ASN SEQRES 25 A 327 VAL GLU PRO PHE ALA LYS GLU PHE GLY LEU GLN SER MET SEQRES 26 A 327 LEU LEU SEQRES 1 B 7 HIS GLU GLU LEU ALA LYS LEU FORMUL 3 HOH *67(H2 O) HELIX 1 1 ASN A 351 ALA A 363 1 13 HELIX 2 2 ASN A 364 ALA A 379 1 16 HELIX 3 3 ARG A 382 ASN A 396 1 15 HELIX 4 4 LYS A 398 ASP A 413 1 16 HELIX 5 5 ASP A 416 HIS A 431 1 16 HELIX 6 6 ASN A 432 SER A 446 1 15 HELIX 7 7 ALA A 478 ASN A 496 1 19 HELIX 8 8 ASP A 499 SER A 513 1 15 HELIX 9 9 ASN A 515 ARG A 530 1 16 HELIX 10 10 ASP A 533 GLY A 547 1 15 HELIX 11 11 ARG A 549 ASN A 564 1 16 HELIX 12 12 TYR A 567 MET A 581 1 15 HELIX 13 13 GLN A 583 GLY A 600 1 18 HELIX 14 14 ALA A 608 MET A 627 1 20 HELIX 15 15 ARG A 629 LEU A 635 1 7 HELIX 16 16 VAL A 641 PHE A 648 1 8 CRYST1 44.390 66.360 49.680 90.00 105.13 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022528 0.000000 0.006091 0.00000 SCALE2 0.000000 0.015069 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020852 0.00000